Watch for Three New Antiepileptics

August 2014

You'll see three new antiepileptic drugs called Qudexy XR (cue-DEKS-ee), Fycompa (fi-COM-puh), and Aptiom (AP-tee-om).

Qudexy XR (topiramate extended-release) will compete with Trokendi XR as a once-daily alternative to topiramate immediate-release.

These once-daily brands will cost $140 to $560/month for 25 to 200 mg/day...compared to under $30/month for topiramate immediate-release.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote